Hydronephrosis Is an Independent Predictor of Poor Clinical Outcome in Patients Treated for Muscle-Invasive Transitional Cell Carcinoma With Radical Cystectomy

Urology

Volumn 72, Issue 2, 2008, Pages 379-383

  Canter, Daniel ^a   Guzzo, Thomas J ^b   Resnick, Matthew J ^a   Brucker, Benjamin ^a   Vira, Manish ^a   Chen, Zhen ^c   Tomaszewski, John ^a   VanArsdalen, Keith ^a   Wein, Alan J ^a   Malkowicz, S Bruce ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYSTECTOMY; DIAGNOSTIC IMAGING; FEMALE; HAZARD RATIO; HUMAN; HYDRONEPHROSIS; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUSCLE METASTASIS; PREDICTIVE VALIDITY; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FORECASTING; HUMANS; HYDRONEPHROSIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 48349099513     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.03.053     Document Type: Article

References (18)

1. Kirkali Z., Chan T., Manoharan M., et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66 Suppl 1 (2005) 4-34
2. Dinney C.P. Therapy of invasive bladder cancer. Urology 67 3 Suppl 1 (2006) 56-61
3. Malkowicz S.B., van Poppel H., Mickisch G., et al. Muscle-invasive urothelial carcinoma of the bladder. Urology 69 Suppl 1 (2007) 3-16
4. Turkolmez K., Tokgoz H., Resorlu B., et al. Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors. Urology 70 (2007) 477-481
5. Bochner B.H., Kattan M.W., and Vora K.C. Postoperative nomogram predicating risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 24 (2006) 3967-3972
6. Karakiewicz P.I., Shariat S.F., Palapattu G.S., et al. Precystectomy nomogram for prediction of advanced bladder cancer. Eur Urol 50 (2006) 1254-1260
7. Lotan Y., Gupta A., Shariat S.F., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533-6539
8. Habuchi T., Marberger M., Droller M.J., et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 66 (2005) 64-74
9. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51 (2007) 137-151
10. Ficarra V., Dalpiaz O., Alrabi N., et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95 (2005) 786-790
11. Haleblian G.E., Skinner E.C., Dickinson M.G., et al. Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol 160 (1998) 2011-2014
12. Leibovitch I., Ben-Chaim J., Ramon J., et al. The significance of ureteral obstruction in invasive transitional cell carcinoma of the urinary bladder. J Surg Oncol 52 (1993) 31-35
13. Bartsch G.C., Kuefer R., Gschwend J.E., et al. Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. Eur Urol 51 (2007) 690-698
14. Yu R., Goldfarb M., and Bayuk J. Hydronephrosis and survival rate in bladder cancer. Int Surg 55 (1971) 283-287
15. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
16. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancerupdate of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48 (2005) 202-206
17. Winquist E., Kirchner T.S., Segal R., et al. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. J Urol 171 (2004) 561-569
18. Herr H.W., Dotan Z., Donat S.M., et al. Defining optimal therapy for muscle invasive bladder cancer. J Urol 177 (2007) 437-443